NIT
XLRN

NumerixS Investment Technologies’s Acceleron Pharma XLRN Stock Holding History

NumerixS Investment Technologies’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-100
Closed -$4K – 1301
2019
Q3 		$4K Hold
100
– – ﹤0.01% 975
2019
Q2 		$4K Buy
+100
New +$4.14K ﹤0.01% 1012
2018
Q2 		– Sell
-1,000
Closed -$39K – 1424
2018
Q1 		$39K Buy
+1,000
New +$42.5K 0.01% 861
2017
Q1 		– Sell
-3,600
Closed -$92K – 1446
2016
Q4 		$92K Buy
3,600
+2,100
+140% +$66.5K 0.01% 877
2016
Q3 		$54K Sell
1,500
-2,400
-62% -$79.5K 0.01% 950
2016
Q2 		$133K Buy
+3,900
New +$127K 0.02% 814

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

NumerixS Investment Technologies's XLRN Position: Q4 2019 in Review

NumerixS Investment Technologies sold out of Acceleron Pharma (XLRN) in Q4 2019, closing a stake of 100 shares — an estimated $4K sold.

NumerixS Investment Technologies first reported a position in XLRN in Q2 2016 and held it in 6 quarters. The position peaked at $133K in Q2 2016. 183 funds tracked by Wall St. Rank hold XLRN as of Q4 2019.

  • NumerixS Investment Technologies reported no remaining Acceleron Pharma position as of Q4 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 100 Acceleron Pharma shares in Q4 2019, an estimated $4K.
  • NumerixS Investment Technologies first reported a position in Acceleron Pharma in Q2 2016 and held it in 6 quarters.
  • NumerixS Investment Technologies's Acceleron Pharma position peaked at $133K in Q2 2016.
  • 183 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2019.

Based on NumerixS Investment Technologies's 13F filing for Q4 2019, filed 12 Feb 2020.